InMed’s Study Highlights Cannabinol’s Potential in Skincare

InMed Pharmaceuticals (INM) has released an update.

InMed Pharmaceuticals has published a promising study showcasing the anti-inflammatory effects of cannabinol (CBN) on skin diseases, highlighting its potential for therapeutic and cosmetic applications. This research emphasizes CBN’s ability to modulate the endocannabinoid system and regulate inflammation in conditions such as psoriasis and dermatitis. The findings could pave the way for new treatments targeting inflammation in various diseases.

For further insights into INM stock, check out TipRanks’ Stock Analysis page.